Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time-slot availability.SummaryDifference0.8%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while removing specific location details such as state, country, and city information.SummaryDifference9%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%
- Check39 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.16.11) and a new completion date of August 7, 2025. The previous revision (v2.16.10) and an outdated date of July 9, 2024, have been removed.SummaryDifference2%
- Check47 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.